Susquehanna Fundamental Investments’s Myovant Sciences Ltd. MYOV Stock Holding History

Susquehanna Fundamental Investments’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,357	Closed	-$161K	–	1738
2021 Q4	$161K	Sell	10,357 -2,443	-19%	-$46.6K	﹤0.01%	1286
2021 Q3	$287K	Buy	+12,800	New	+$281K	0.01%	1421
2021 Q2	–	Sell	-12,100	Closed	-$249K	–	1825
2021 Q1	$249K	Hold	12,100	–	–	﹤0.01%	1345
2020 Q4	$334K	Hold	12,100	–	–	0.01%	1243
2020 Q3	$170K	Hold	12,100	–	–	0.01%	1223
2020 Q2	$250K	Buy	+12,100	New	+$165K	0.01%	796

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Susquehanna Fundamental Investments's MYOV Position: Q1 2022 in Review

Susquehanna Fundamental Investments sold out of Myovant Sciences Ltd. (MYOV) in Q1 2022, closing a stake of 10,357 shares — an estimated $161K sold.

Susquehanna Fundamental Investments first reported a position in MYOV in Q2 2020 and held it in 6 quarters. The position peaked at $334K in Q4 2020. 89 funds tracked by Wall St. Rank hold MYOV as of Q1 2022.

Susquehanna Fundamental Investments reported no remaining Myovant Sciences Ltd. position as of Q1 2022 after selling out during the quarter.
Susquehanna Fundamental Investments sold 10,357 Myovant Sciences Ltd. shares in Q1 2022, an estimated $161K.
Susquehanna Fundamental Investments first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 6 quarters.
Susquehanna Fundamental Investments's Myovant Sciences Ltd. position peaked at $334K in Q4 2020.
89 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.